January 13, 2011 -- United Laboratories International will invest 1 billion RMB ($150 million) to gain a foothold in China’s insulin market. Last week, the company announced it received SFDA approval for three insulin products, bringing its total to five. At the time, United Labs said it would spend about $75 million to establish its presence in the sector. The company hopes to gain a 10% share of China’s insulin market within three years. More details....
